Latest News
A multidisciplinary team of Yale scientists has received a $4-million federal grant to study the effectiveness of a new vaccine and monoclonal antibody shot designed to prevent respiratory syncytial virus (RSV) in infants.
- February 13, 2024
The Connecticut Emerging Infections Program (EIP) at the Yale School of Public Health has received a five-year grant totaling approximately $19.5 million from the U.S. Centers for Disease Control and Prevention, with an initial $3.9 million being awarded in the first year. Linda Niccolai, professor of epidemiology (microbial diseases) and associate dean for academic affairs, is the principal investigator.
- February 06, 2024
Sangini Sheth, MD, MPH, participates in a Q&A for National Cancer Prevention Month.
- November 22, 2023
New HIV medications could be on the horizon after research uncovers how HIV-1, the most common type of HIV, binds to T cells.
- October 11, 2023
A new study led by Yale scientists shows that the activity of a portion of a human papillomavirus (HPV) protein does not depend on its amino acid sequence or composition.
- May 22, 2023
In classrooms across the United States, five to 10 million children struggle with dyslexia. While offering intervention strategies in grades 1 through 3 can drastically improve the trajectory of a student’s education, the window for effective intervention is narrow. That makes early and accurate screening key. Now, researchers are discovering clues in our genes that could speed early assessment of the risk of dyslexia.
- January 11, 2022
In recognition of Cervical Cancer Awareness Month, Sangini Sheth, MD, MPH, Associate Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale Cancer Center, shares her motivation for caring for patients with cervical cancer and researching new therapies for the disease
- November 17, 2021Source: US News
Young people were more likely to have received an HPV vaccine in places where they could give consent without their parents, researchers found, improving access to an important tool for cancer prevention.
- November 15, 2021
Several Yale Cancer Center faculty have authored chapters in a newly released book, A New Deal For Cancer: Lessons from a 50 Year War.
- November 14, 2021
The human papillomavirus (HPV) vaccine, which is recommended for children between ages 11 and 12, is highly effective at preventing cervical cancer. But in the United States, only 54% of adolescents are fully vaccinated against HPV, a rate lower than those of other adolescent vaccines, including those preventing meningitis, tetanus, diphtheria, and pertussis.